Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL

Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL is a concentrate used for allergen immunotherapy. This product, manufactured by Greer Laboratories, Inc., is designed to help manage allergic reactions to dust mites.

Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL is primarily used in allergen immunotherapy to reduce sensitivity to dust mite allergens. It is often administered to individuals who experience allergic reactions such as sneezing, itching, or skin rashes due to exposure to dust mites. This treatment aims to desensitize the immune system over time, potentially reducing the severity of allergic symptoms.

The effects of Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL can vary among individuals. Some may experience localized reactions at the injection site, such as redness or swelling. Over time, the treatment may help reduce the frequency and severity of allergic symptoms triggered by dust mites.

It is important to use Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL under the guidance of a healthcare professional. Individuals with a history of severe allergic reactions should be monitored closely. Always follow the prescribed administration route, which may include intradermal, percutaneous, or subcutaneous methods.

Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL may interact with other medications or treatments. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.